Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on May 12, 2025
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 12, 2025
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 152, …
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $185 million, a $25 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $100 million Transaction …
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
GlobeNewswire
·
May 12, 2025
Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) Top-line MaGic results anticipated in September 2025 to be the first of three catalysts for the DNTH103 neuromuscular franchise by YE’26 Phase 3 CAPTIVATE trial …
Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
On track to report topline data from NMRA-511 in Alzheimer’s disease agitation around the end of 2025 Resumed enrollment for KOASTAL-3 and -2 studies in March 2025; anticipate reporting topline major depressive disorder data from KOASTAL-3 in the first …
Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Submitted NDA for Anaphylm™ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval Company to host …
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
GlobeNewswire
·
May 12, 2025
JERUSALEM, May 12, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that Mr. Nadav Kidron, the President, CEO, …
Assertio Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Sustainable Near-Term Growth and Increased Long-Term Value LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) …
Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Positive initial Phase 2 proof-of-concept data for NDV-01 at AUA 2025 showing a 90% overall response rate at any time in non-muscle invasive bladder cancer (US prevalence 600K patients) The Phase 2 study for NDV-01 continues with updates at 6, 9 and 12 …
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 12, 2025
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in …
BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 12, 2025
Preliminary net revenue increased 73% to $72.5 million for Q1 2025, compared to $41.9 million in Q1 2024 Achieved preliminary GAAP net income of $4.5 million, or $0.27 per share Reported preliminary Q1 2025 Adjusted EBITDA of $7.8 million Quarter-end cash …
Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 12, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, …
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and …
Heroes on the Water Observes National Police Week Focusing on Officer Wellness, Cumulative PTSD
GlobeNewswire
·
May 12, 2025
Allen, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- National Police Week is a time to remember officers who have made the ultimate sacrifice, and a time to recognize the everyday cost of service carried by those still on the job. This year, Heroes on the Water …
The Joint Commission and National Quality Forum announce recipients of 2024 Eisenberg Patient Safety and Quality Awards
GlobeNewswire
·
May 12, 2025
OAKBROOK TERRACE, Illinois, May 12, 2025 (GLOBE NEWSWIRE) -- The Joint Commission and the National Quality Forum (NQF) today announced the recipients of the 2024 John M. Eisenberg Patient Safety and Quality Awards. The Eisenberg Awards, named in honor of …
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated
GlobeNewswire
·
May 12, 2025
MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independent investigation into previously disclosed allegations from …
Best Cortisol Supplements 2025: CortiSync Under Review & Top Stress Relief Pills That Work
GlobeNewswire
·
May 12, 2025
Limassol, Cyprus, May 12, 2025 (GLOBE NEWSWIRE) -- Introduction: Best Supplements for High Cortisol 2025 – CortiSync Modern life is fast-paced, demanding, and filled with pressures that can take a toll on both the mind and body. At the center of this …
Services-Conseils en Ergonomie devient ERGOVIA
GlobeNewswire
·
May 12, 2025
SHERBROOKE, Québec, 12 mai 2025 (GLOBE NEWSWIRE) -- SCE Services-Conseils en Ergonomie devient ERGOVIA. Ce changement de nom s’accompagne d’une toute nouvelle image de marque. Cette évolution s'inscrit dans une démarche stratégique visant à mieux refléter …
Nurses Speak Out on Burnout, Balance, and the Future of the Profession in New Survey
GlobeNewswire
·
May 12, 2025
DALLAS, May 12, 2025 (GLOBE NEWSWIRE) -- While 75% of nurses report being satisfied with their career choice, many still face significant strain due to burnout, mental health challenges, and staffing issues, according to a new survey by AMN Healthcare, the …
InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease
GlobeNewswire
·
May 12, 2025
InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease Lille, May 12, 2025 – InBrain Pharma, a clinical stage biotech …
Porch Light Health Acquires Comprehensive Behavioral Health Center to Expand Access to Full-Spectrum Addiction Treatment
GlobeNewswire
·
May 12, 2025
DENVER, May 12, 2025 (GLOBE NEWSWIRE) -- Porch Light Health, the largest addiction medicine practice in Colorado, offering outpatient Medications for Addiction Treatment (MAT) at more than 60 treatment locations, is proud to announce the acquisition of …